Op-Ed: Why Banning PBM-Owned Pharmacies Risks Patient Care

Back to Multimedia Center

Key Takeaways

  • National PBM reforms should target transparency and rebate pass-through while protecting patient access to high-quality care.
  • The pause on Arkansas’s Act 624 allows for reconsideration of its impact on specialty pharmacy services and patient care access.
  • Specialty pharmacies provide essential coordinated care for complex conditions, which standard pharmacies may not consistently offer.
  • Policymakers should prioritize patient outcomes and effective care models over ownership structures when addressing PBM practices.
Read More